NVO Novo Nordisk A/S

NVO Novo Nordisk A/S

Healthcare · Drug Manufacturers - General

Market read

Scan convergence 1 scan as of 2026-08-14 1 neutral converging

POC $46.53 · VWAP $46.86 · -4.2% vs 12m avg buyer

pullback vol: normalchurn: quiet as of

Insiders no data — outside the Form 4 poll — US-filer feed only (foreign filers report via MAR managers'-transactions notices)

Coverage

1 related perspective

NVO Price Structure

Loading chart…

Loading timeframes…

Peers

Every watchlist NVO belongs to, members best 30-day change first — NVO highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.

@peptide-economy
@biotech-scan

Next earnings NVO reports in 78 days Nov 4

Last report Aug 4

Reported EPS $6.18 versus analyst consensus of $4.98 (+24.0%).

full note →

Against street estimates

How NVO's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.

8 most recent of 11 quarters · newest report Aug 4 · projection Aug 17

Result
Aug 4 4.986.18+24.0%Beat
May 5 6.966.63-4.8%Miss
Feb 3 5.906.04+2.3%Beat
Nov 5 '25 4.244.50+6.0%Beat
Aug 6 '25 6.005.96-0.7%In line
May 7 '25 6.076.53+7.5%Beat
Feb 4 '25 5.976.34+6.2%Beat
Nov 6 '24 5.926.12+3.4%Beat

News (last pull)

Headlines about NVO from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.

pulled 35 days ago · Jul 14

Types
Aug 5 Catalyst NVO earnings
NVO
Aug 4 Catalyst NVO earnings
NVO
May 6 Catalyst NVO earnings
NVO